Now, more than 25 years into her journey with vitiligo, Lisa reflects on the impact of vitiligo and how she’s managed the ...

Blood clots are a common-and potentially serious-medical condition that affects up to 900,000 U.S. adults every year, ...

July 17, 2024 — A medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according to new ... New Study Finds 40-Percent of ...

Saint Francis treated its first patient with pulsed-field ablation, which delivers pulsed electric fields to tissue to treat ...

Emergency room doctors confirmed there were life-threatening blood clots in her lungs ... She’s seeing a lung and blood doctor to figure out treatment moving forward. Reiche said she’s never been so ...

All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the ...

for treating non-small-cell lung cancer (NSCLC) in adults whose cancer: is resectable (tumours 4 cm or over, or node positive) and has no epidermal growth factor receptor (EGFR) mutations or ...

and precise thrombectomy solution for treating life-threatening blood clots,” said Dr. Jun Li, Co-Director of the Vascular Center and Pulmonary Embolism Response Team at University Hospitals ...

A blood test that searches for tiny fragments of tumours could predict which lung cancer patients need more intensive treatment. The NeXT Personal test can detect one part per million of ...

US biotech PureTech is to develop its most advanced pipeline drug LYT-100 as a potential treatment for inflammation and lung scarring in patients who have serious cases of COVID-19 or who have ...

Professor Charles Swanton, Chief Investigator of the CRUK TRACERx study from UCL Cancer Institute, the Crick and UCLH, and senior author of the study, said: “Lung cancer is one of the most common ...